Literature DB >> 17959656

Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis.

Ping Zhang1, Bertram L Jacobs, Charles E Samuel.   

Abstract

The E3L proteins encoded by vaccinia virus bind double-stranded RNA and mediate interferon resistance, promote virus growth, and impair virus-mediated apoptosis. Among the cellular proteins implicated as targets of E3L is the protein kinase regulated by RNA (PKR). To test in human cells the role of PKR in conferring the E3L mutant phenotype, HeLa cells stably deficient in PKR generated by an RNA interference-silencing strategy were compared to parental and control knockdown cells following infection with either an E3L deletion mutant (DeltaE3L) or wild-type (WT) virus. The growth yields of WT virus were comparable in PKR-sufficient and -deficient cells. By contrast, the single-cycle yield of DeltaE3L virus was increased by nearly 2 log(10) in PKR-deficient cells over the impaired growth in PKR-sufficient cells. Furthermore, virus-induced apoptosis characteristic of the DeltaE3L mutant in PKR-sufficient cells was effectively abolished in PKR-deficient HeLa cells. The viral protein synthesis pattern was altered in DeltaE3L-infected PKR-sufficient cells, characterized by an inhibition of late viral protein expression, whereas in PKR-deficient cells, late protein accumulation was restored. Phosphorylation of both PKR and the alpha subunit of protein synthesis initiation factor 2 (eIF-2alpha) was elevated severalfold in DeltaE3L-infected PKR-sufficient, but not PKR-deficient, cells. WT virus did not significantly increase PKR or eIF-2alpha phosphorylation in either PKR-sufficient or -deficient cells, both of which supported efficient WT viral protein production. Finally, apoptosis induced by infection of PKR-sufficient HeLa cells with DeltaE3L virus was blocked by a caspase antagonist, but mutant virus growth was not rescued, suggesting that translation inhibition rather than apoptosis activation is a principal factor limiting virus growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17959656      PMCID: PMC2224564          DOI: 10.1128/JVI.01891-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  A role for Z-DNA binding in vaccinia virus pathogenesis.

Authors:  Yang-Gyun Kim; Maneesha Muralinath; Teresa Brandt; Matthew Pearcy; Kevin Hauns; Ky Lowenhaupt; Bertram L Jacobs; Alexander Rich
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-30       Impact factor: 11.205

2.  Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2 alpha protein kinase.

Authors:  S J McCormack; D C Thomis; C E Samuel
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

3.  Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase.

Authors:  J Kitajewski; R J Schneider; B Safer; S M Munemitsu; C E Samuel; B Thimmappaya; T Shenk
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

4.  Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase.

Authors:  J C Watson; H W Chang; B L Jacobs
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

Review 5.  The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans.

Authors:  C E Samuel
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

6.  Mechanism of interferon action. Increased phosphorylation of protein synthesis initiation factor eIF-2 alpha in interferon-treated, reovirus-infected mouse L929 fibroblasts in vitro and in vivo.

Authors:  C E Samuel; R Duncan; G S Knutson; J W Hershey
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

7.  Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase.

Authors:  C E Samuel
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

8.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase.

Authors:  H W Chang; J C Watson; B L Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

9.  Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope.

Authors:  S N Isaacs; E J Wolffe; L G Payne; B Moss
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene.

Authors:  Qingde Wang; Mana Miyakoda; Weidong Yang; Jaspal Khillan; David L Stachura; Mitchell J Weiss; Kazuko Nishikura
Journal:  J Biol Chem       Date:  2003-11-12       Impact factor: 5.157

View more
  60 in total

1.  Host response to polyomavirus infection is modulated by RNA adenosine deaminase ADAR1 but not by ADAR2.

Authors:  Cyril X George; Charles E Samuel
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Essential role of protein kinase R antagonism by TRS1 in human cytomegalovirus replication.

Authors:  Jacquelyn E Braggin; Stephanie J Child; Adam P Geballe
Journal:  Virology       Date:  2015-12-21       Impact factor: 3.616

3.  Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus.

Authors:  Zhiqun Li; Kristina M Okonski; Charles E Samuel
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Species specificity of protein kinase r antagonism by cytomegalovirus TRS1 genes.

Authors:  Stephanie J Child; Greg Brennan; Jacquelyn E Braggin; Adam P Geballe
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

5.  Viral double-stranded RNAs from vaccinia virus early or intermediate gene transcripts possess PKR activating function, resulting in NF-kappaB activation, when the K1 protein is absent or mutated.

Authors:  Kristen L Willis; Jeffrey O Langland; Joanna L Shisler
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

Review 6.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

7.  The double-stranded RNA binding domain of the vaccinia virus E3L protein inhibits both RNA- and DNA-induced activation of interferon beta.

Authors:  Jean-Baptiste Marq; Stéphane Hausmann; Jeremy Luban; Daniel Kolakofsky; Dominique Garcin
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

8.  Binding and relocalization of protein kinase R by murine cytomegalovirus.

Authors:  Stephanie J Child; Adam P Geballe
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

9.  Species-specific inhibition of antiviral protein kinase R by capripoxviruses and vaccinia virus.

Authors:  Chorong Park; Chen Peng; Greg Brennan; Stefan Rothenburg
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

10.  Suppression of NYVAC Infection in HeLa Cells Requires RNase L but Is Independent of Protein Kinase R Activity.

Authors:  Mercedes Fernández-Escobar; José Luis Nájera; Sara Baldanta; Dolores Rodriguez; Michael Way; Mariano Esteban; Susana Guerra
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.